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Abstract
Exosomes are endosome-derived membrane vesicles that contain proteins, lipids, and
nucleic acids. The exosomal transcriptome mediates intercellular communication, and rep-
resents an understudied reservoir of novel biomarkers for human diseases. Next-generation
sequencing enables complex quantitative characterization of exosomal RNAs from diverse
sources. However, detailed protocols describing exosome purification for preparation of
exosomal RNA-sequence (RNA-Seq) libraries are lacking. Here we compared methods for
isolation of exosomes and extraction of exosomal RNA from human cell-free serum, as well
as strategies for attaining equal representation of samples within pooled RNA-Seq libraries.
We compared commercial precipitation with ultracentrifugation for exosome purification and
confirmed the presence of exosomes via both transmission electron microscopy and immu-
noblotting. Exosomal RNA extraction was compared using four different RNA purification
methods. We determined the minimal starting volume of serum required for exosome prepa-
ration and showed that high quality exosomal RNA can be isolated from sera stored for over
a decade. Finally, RNA-Seq libraries were successfully prepared with exosomal RNAs
extracted from human cell-free serum, cataloguing both coding and non-coding exosomal
transcripts. This method provides researchers with strategic options to prepare RNA-Seq
libraries and compare RNA-Seq data quantitatively from minimal volumes of fresh and archi-
val human cell-free serum for disease biomarker discovery.
Introduction
Exosomes are extracellular vesicles formed when the plasma membrane fuses with multivesi-
cular bodies produced by inward budding late endosomes [1]. Exosomes are ~30–100 nm in
size and are found in many tissues and in a diverse array of biological fluids including serum,
plasma, amniotic fluid, ascites, bile, breast milk, cerebrospinal fluid, nasal secretions, saliva,
semen, tears, and urine [2–12]. In addition, most cell types secrete exosomes in vitro [7, 13].
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Exosomes carry proteins, lipids, and nucleic acids [14]. Proteomic studies have isolated thou-
sands of proteins in exosomes [15] including both ubiquitous and cell-type specific proteins
that reflect the cell-of-origin [13]. Several members of the tetraspanin protein family, including
CD9, CD63, CD81 and CD82, are highly enriched in almost all exosomes isolated from different
types of cells in vitro and in vivo [13,16]. Transmembrane integrins displayed on the surface of
exosomes determine the target cell type and contribute to organotropic metastasis in cancer
[17]. Lipidomic analyses have identified the predominant species of lipids in exosomes, the
function of which are mostly unknown [18]. In addition, recent evidence shows that exosomes
contain abundant nucleic acids [15]. Single and double stranded genomic DNA as well as mito-
chondrial DNA has been described [19–21] and transcriptomic analyses have catalogued both
protein-coding messengers and non-coding RNAs (ncRNAs) packaged within exosomes [15].
Exosomal messenger RNAs (mRNAs) are transported via exosomes and can be translated into
proteins once brought into recipient cells, indicating exosomal mRNAs play a regulatory role in
non-cell autonomous signaling [22]. Among the small ncRNAs, microRNAs (miRNAs) are the
most abundant and consequently, have been the focus of most exosome biomarker research
and functional studies [23, 24]. Other small exosomal ncRNAs include piwi-interacting RNAs
(piRNAs), ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs), and small nucleolar
RNAs (snoRNAs) [23–27]. In addition, long ncRNAs (lncRNAs), long intergenic RNAs (lincR-
NAs) and circular RNAs are also present in exosomes [23, 25, 27, 28].
Stabilized within RNA-protein complexes and shielded by lipid bilayer, exosomal RNAs repre-
sent a promising source of diagnostic and prognostic biomarkers for human diseases [29, 30].
Since the identification of RNAs in exosomes in 2007 [22], profiling of exosomal RNAs by RNA-
sequencing (RNA-Seq) has been performed on a handful of exosomal preparations from cell
lines, and body fluids including plasma, urine and serum [26, 31–33]. However, it is technically
challenging to perform enrichment and molecular profiling of exosomes [34], particularly in sce-
narios where individual clinical samples are limited, and where large numbers of samples need to
be processed in a uniform and efficient manner. Here, we describe a detailed protocol encom-
passing exosomal purification and validation from human cell-free serum, exosomal RNA extrac-
tion and preparation of exosomal RNA-Seq libraries from fresh and archived sera specimens.
Materials and methods
Preparation of human cell-free serum
For fresh specimens, blood samples were collected from six healthy subjects via the antecubital
vein. Plasma was immediately isolated by centrifugation at 3,000 g for 10 min at room tempera-
ture. Supernatants were collected and centrifuged at 4,000 g for 15 min at room temperature to
remove trace number of cells. Cell-free sera were used immediately, or aliquoted and stored at
-80˚C. Before isolation of exosomes, each aliquot was centrifuged at 8,000 g for 30 mins then
12,000 g for 30 min at 4˚C, to ensure complete removal of cell debris and shedding microvesi-
cles. Archival blood samples from 105 patients were collected as part of the Women’s Cancer
Program Biobank at Cedars-Sinai Medical Center (CSMC). Only female participants over 18
years of age were included in the study. All underwent surgery at CSMC for a variety of gyneco-
logical conditions including but not limited to fibroids, endometriosis and ovarian cancer. All
samples were collected with informed patient consent, and specimen collection and exosome
characterization was performed with the approval of the CSMC Institutional Review Board.
Enrichment of exosomes from human sera
Isolation of exosomes using ExoQuick. Cell-free serum with a volume of 500 μL was
thawed on ice. Serum was mixed with 126 μL of ExoQuick (System Biosciences, catalogue
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number: EXOQ5A-1). The mixture was incubated at 4˚C for 2 h and centrifuged at 1,500 g for
30 min at 4˚C. Each specimen was centrifuged twice at 12,000 g for 2 min to remove any addi-
tional supernatant. Once isolated, pelleted exosomes were resuspended in 150 μL nuclease-free
water.
Isolation of exosomes by ultracentrifugation. Cell-free serum with a volume of 500 μL
was thawed on ice, overlaid onto a 15% sucrose cushion and ultracentrifuged at 150,000 g for
16 h at 4˚C using SW60Ti rotors (Beckman Coulter). Pelleted exosomes were resuspended in
100 μL 1×PBS by overnight incubation at 4˚C and then were ultracentrifuged at 150,000 g at
4˚C for 2 h. Pelleted exosomes were resuspended in 150 μL of nuclease-free water.
Transmission electron microscopy (TEM)
Specimens were placed onto freshly glow-discharged 300 mesh carbon formvar grids and set
for 10 min. The solution was wicked away with filter paper, and 5 μL 2% glutaraldehyde was
placed on the grid for 3 min. The grid was wicked dry, rinsed with water and stained with 2%
uranyl acetate for 1 min. Each grid was then wicked and air-dried for 10 min before examining
at 80 kV on a JEOL 100CX transmission electron microscope at Electron Microscopy Core
Facility of Brain Research Institute at University of California, Los Angeles (UCLA). Images
were obtained via a chamberscope film camera.
Western blotting
To prepare exosomes for western blotting, exosomes isolated by ExoQuick were layered over a
15% sucrose cushion and were ultracentrifuged at 150,000 g at 4˚C for 2 h. Pelleted exosomes
were resuspended in 150 μL nuclease-free water overnight at 4˚C. Exosomes isolated by ultra-
centrifugation did not require additional processing. Each sample was mixed with 4×Laemmli
Sample Buffer and heated at 95˚C for 10 min before being loaded for electrophoresis. The
membrane was incubated with a primary rabbit anti-CD63 antibody (1:1000 dilution, Santa
Cruz Biotechnology, catalogue number: sc-15363, RRID: AB_648179) overnight at 4˚C on a
shaker. Membranes were washed with TBS/0.2% Tween 20 three times at 15-min interval. The
goat anti-rabbit IRDye 680 RD secondary antibody (1:10,000 dilution, Li-COR, catalogue
number: 925–68071) was then incubated with the membrane for 1 h at room temperature.
Blots were imaged using the Li-COR Odyssey scanner after wash.
Exosomal RNA extraction
Exosomal RNA isolation via TRIzol LS and the RNeasy Mini Kit. Exosomal RNAs were
isolated using a combination of phase separation and the RNeasy Mini Kit (Qiagen, catalogue
number: 74106). TRIzol LS reagent (500 μL) (Thermo Fisher Scientific, catalogue number:
10296–028) and chloroform (200 μL) were added to each sample. Samples were mixed thor-
oughly by shaking for over 30 secs and incubated at room temperature for 10 min. Phase sepa-
ration was performed by centrifugation at 12,000 g at 4˚C for 15 min. The upper aqueous
phase was collected. Then RLT buffer (3.5×volume), absolute ethanol (2.5×volume), and
sodium acetate [3M, pH 5.5] (0.1×volume) (Ambion, catalogue number: AM9740) were
added. RNA was extracted using the RNeasy Mini Kit, according to the manufacturer’s
instructions. RNA was quantified using the Nanodrop ND-1000 (Thermo Fischer Scientific).
Exosomal RNA isolation via RNeasy Mini Kit. The RNeasy Mini Kit was used to extract
exosomal RNAs according to the manufacturer’s protocol. RNA was quantified using the
Nanodrop.
Exosomal RNA precipitation. Exosomal RNAs were phase-separated as described above.
The upper aqueous phase was collected and 10% volume of sodium acetate (3 M, pH 5.5) was
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added to each sample. Four microliters glycogen (5 mg/mL, catalogue number: AM9510) and
2.5 times the acquired aqueous volume of absolute ethanol were added. Samples were mixed,
incubated overnight at -80˚C and then centrifuged at 16,000 g at 4˚C for 30 min to pellet RNA.
The pellet was washed with 70% ethanol and centrifuged at 16,000 g at 4˚C for 5 min. Ethanol
was aspirated and the pellet was centrifuged again to remove additional supernatant. Pellets
were dried for 5 min before being resuspended in 32 μL of nuclease-free water and purified
RNA was quantified using Nanodrop.
Exosomal RNA isolation via AllPrep DNA/RNA Mini Kit. The AllPrep DNA/RNA
Mini kit (Qiagen, catalogue number: 80204) was used to extract exosomal RNAs following the
manufacturer’s protocol. RNA was quantified using the Nanodrop.
RNA-Seq library preparation and next-generation sequencing
Twenty nanograms exosomal RNA was used to prepare each RNA-Seq library. External RNA
Controls Consortium (ERCC) spike-ins (Thermo Fischer Scientific, catalogue number:
4456740) were added as control for normalization of the samples. Strand-specific RNA-Seq
libraries were constructed using the NEBNext Ultra Directional RNA Library Prep Kit (NEB,
catalogue number: E7420) with the following adjustments to the manufacturer’s instructions:
fragmentation was performed for 1 min at 94˚C given the size range of our exosomal RNA was
typically smaller than 1000 bp (data not shown), and PCR was set to 15 cycles. A unique index
was ligated to each sample using the NEBNext Multiplex Oligos for Illumina Index Primers
Sets 1–4 (NEB, catalogue numbers: E7335S, E7500S, E7710S, and E7730S). The resulting
library concentrations were quantified using the Nanodrop, a Library Quantification Kit
(Kapa Biosystems, catalogue number: KK4824), and the Bioanalyzer 2100 (Agilent). The
KAPA Kit contains Library Quantification DNA Standards 1–6 (a 10-fold dilution series of a
linear, 452 bp template) and a Library Quantification Primer Premix. The sequences of prim-
ers are 5'-AATGATACGGCGACCACCGA-3' and 5'-CAAGCAGAAGACGGCATACGA-3'.
Libraries were sequenced to generate single-end 75 bp reads on NextSeq 500 platform (Illu-
mina) in high output running mode. Sequencing was performed at the Molecular Genomics
Core facility at the University of Southern California.
RNA-Seq data processing, alignment and analysis
Raw data were downloaded as FASTQ files and QC performed using MultiQC [35]. Around
10 million reads were generated for each sample. The raw data was pre-processed using Trim-
galore version 0.4.2 [36] to remove Illumina adapters and reads shorter than 20 bp. Trimmed
reads were aligned to version hg38 of the human genome reference sequence using STAR [37].
Mapped reads were then matched to genomic features (i.e. mRNAs and lncRNAs) annotated
in GENCODE25 [38] and ERCC annotations using Rsubread package, version 1.24.0 [39], to
generate raw counts for each gene. Raw read count data were normalized to ERCC spike-in
values across samples using Bioconductor package RUVSeq_1.8.0 [40]. We removed non-
expressed genes by requiring more than 5 reads for each gene. R Bioconductor package
NOISeq was used evaluate and access the quality control of the count data [41].
Statistical analysis
Paired Student’s t tests were used to calculate P-values when comparing methods for exosomal
RNA extraction. One-way ANOVA was applied to calculate a P-value when contrasting exoso-
mal RNA extraction from different serum volumes. Spearman’s rank correlations were utilized
to decide significance of the correlations between RNA yield or OD260/OD280 with storage
time. P-values smaller than 0.05 were considered statistically significant.
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RNA-Seq data availability
Exosome RNA-Seq data are publicly available at: https://www.ncbi.nlm.nih.gov/sra/
SRP142765.
Results
Enrichment of exosomes by ultracentrifugation and ExoQuick
A workflow for exosomal enrichment and validation, RNA extraction, and RNA-Seq library
generation is illustrated in Fig 1. Blood samples from six healthy subjects were used to optimize
the methods for exosome purification and exosomal RNA extraction. Exosomes were purified
from equal volumes of cell-free serum using ultracentrifugation or the ExoQuick reagent and
two approaches were then used to validate each approach. First, TEM was used to identify vesi-
cles ranging from 30–100 nm in size. Exosomes were present in all preparations generated
using both the ultracentrifugation and ExoQuick protocols (Fig 2A). Second, as CD63 is found
on the surface of almost all exosomes, we performed Western blotting for CD63 on all samples.
CD63 was detected in exosome preparations from all samples using both protocols, but not
unprocessed serum (Fig 2B). Immunoblotting results detected more CD63 in ExoQuick-iso-
lated exosomes for all six subjects, suggesting ExoQuick enriches sera exosomes more effi-
ciently than ultracentrifugation.
Comparison of exosomal RNA extraction methods
For downstream applications (e.g. real time quantitative PCR (RT-qPCR), gene expression
microarrays or RNA-Seq), both RNA quantity and quality are critical. RNA yield and OD260/
OD280 ratios were therefore compared for exosomal RNA isolated using four different RNA
extraction methods: the RNeasy Mini Kit combined with TRIzol LS, the RNeasy Mini Kit
alone, conventional RNA precipitation, and the AllPrep DNA/RNA Mini Kit (Fig 3).
Fig 1. Flow chart for evaluation of exosomal RNAs from cell-free sera as biomarkers for human diseases. Graphic summary of the workflow including time
allotment for preparation for cell-free serum (steps①-③), comparison of methods for exosome enrichment (step④), validation by transmission electron microscopy
(TEM) and immunoblotting for CD63 or other exosomal markers (step⑤), RNA extraction (step⑥), and preparation of RNA-Seq libraries (step⑦). 10–100
nanograms RNA can be used for library preparation with the NEBNext Ultra Directional RNA Library Prep Kit. Step② is an optional centrifugation step that can be
included to ensure the most efficient removal of trace amounts of cell debris and shedding microvesicles. A validation step can be performed with RT-qPCR for specific
candidate RNA following RNA-Seq analysis (step⑧).
https://doi.org/10.1371/journal.pone.0196913.g001
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Comparisons were performed for exosomes prepared from six healthy subjects using both the
ultracentrifugation and the ExoQuick methods. RNA was successfully extracted in most cases
except for 9 samples where RNA extraction was performed using the AllPrep DNA/RNA Mini
Kit (Fig 3A and 3B), suggesting that this kit may not be suitable for exosomal RNA extraction.
Average total RNA yields for ExoQuick-mediated enrichment of exosomes followed by RNA
extraction with RNeasy with TRIzol LS, RNeasy alone, and RNA precipitation were: 256 ± 76,
129 ± 101, and 1100 ± 446 ng, respectively. Yields for specimens processed by ultracentrifuga-
tion then RNA extraction with RNeasy with TRIzol LS, RNeasy alone, and RNA precipitation
were 195 ± 77, 165 ± 36, and 145 ± 22 ng, respectively (Fig 3A). Nanodrop analysis demon-
strated that RNA yields were highest when ExoQuick was used in conjunction with standard
RNA precipitation, but not with other methods (Fig 3A), each of which use RNeasy columns.
These columns only permit extraction of RNA transcripts over 200 nt in length, whereas con-
ventional precipitation methods retrieve a broader spectrum of RNA species including small
RNAs. This is also supported by higher OD260/OD280 ratio of RNA extracted from ExoQuick
samples using precipitation (Fig 3B). ExoQuick-treated samples generated significant more
total RNA than samples processed using ultracentrifugation, although only when applied in
combination with a traditional RNA precipitation method, suggesting that ExoQuick is more
efficient in retrieving small RNAs than ultracentrifugation. The average quality and yield of
RNA for other methods of RNA extraction was comparable for exosomes prepared by Exo-
Quick and ultracentrifugation (Fig 3A and 3B). In general, RNA yield and quality was most
consistent and less variable when the RNeasy Mini Kit was combined with TRIzol LS, for both
ExoQuick and ultracentrifugation methods.
Fig 2. Validation of exosome enrichment from human cell-free sera. (A) TEM micrographs of exosomes in ultracentrifugation (UC) and ExoQuick (EQ) preparations.
Data for 6 independent patient samples are shown (P1-6). Exosomes confirmed by size (30-100nm) and appearance. Scale bar in each image represents 100 nm. (B)
Immunoblot of CD63 in unprocessed cell-free serum alone (-), UC, and EQ exosomal preparations.
https://doi.org/10.1371/journal.pone.0196913.g002
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Determining the minimum serum volume for exosomal RNA isolation
To determine the minimum volume of cell-free serum required for exosomal RNA isolation,
63 μL, 125 μL, 250 μL and 500 μL aliquots of cell-free serum were subjected to exosomal purifi-
cation using both ultracentrifugation and ExoQuick (Fig 4A). Exosomal enrichment was con-
firmed using anti-CD63 Western blot analysis. CD63 signal was proportional to increasing
sample volume, with a consistently stronger signal observed for ExoQuick treatment com-
pared with ultracentrifugation, again indicating that ExoQuick is more efficient in enrichment
Fig 3. Comparison of sera exosomal RNA using four different RNA extraction methods. (A) Total RNA yield from
ultracentrifugation (UC) and ExoQuick (EQ) treated samples using the RNeasy Mini Kit combined with TRIzol LS,
the RNeasy Mini Kit alone, conventional RNA precipitation, and AllPrep DNA/RNA Mini Kit. (B) Demonstration of
RNA quality measured by OD260/OD280 in EQ and UC treated samples. Data are shown as the mean ± SD from six
independent patient samples. P<0.001, P<0.01, P<0.05, ns, not significant, student’s t test. Note: RNA could not
be extracted from some samples using the AllPrep kit due to clogging.
https://doi.org/10.1371/journal.pone.0196913.g003
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of cell-free exosomes. Using ExoQuick, CD63 could be detected with as little as 63 μL starting
serum, whereas 125 μL serum was required when using ultracentrifugation. RNA was iso-
lated from each ExoQuick prepared sample using the RNeasy Mini Kit combined with TRI-
zol LS. The average yield of total RNA increased proportional to the sample volume (Fig 4B)
and RNA quality was similar for all volumes (Fig 4C). While RNA yield was doubled when
comparing RNA extracted from 500 μL with 250 μL serum, the relationship between sample
volume and yield was non-linear at lower volumes, possibly due to that lower RNA concen-
trations reach the detection limit for the Nanodrop (~2 ng/μL).
Effect of sample age on exosomal RNA quality and yield
We then tested the performance of our optimized exosomal RNA extraction on a cohort of
clinical samples collected over the last 25 years. One hundred and five serum samples were
processed using the ExoQuick reagent followed by RNA extraction using TRIzol LS combined
with the RNeasy Mini Kit. The serum samples were stored at -80˚C immediately after remov-
ing blood cells (see Materials and Methods), and had been stored for an average of 10.3 years
(range: 0.3–25.5). Exosomal RNA was successfully extracted from all samples and crucially,
neither RNA yield or RNA quality was correlated with sample age (Fig 5), indicating exosomal
RNA is highly stable over extended periods of time when serum samples are stored at -80˚C.
Profiling exosomal transcriptomes using RNA-Seq
To demonstrate that exosomal-derived RNA isolated using our optimized method can gener-
ate high quality RNA-Seq data, RNA-Seq libraries were constructed using 20 ng exosomal
RNA from 5 unique sera specimens from healthy women. The average size of inserted exoso-
mal RNAs was around 450 bp (Fig 6A). The concentrations of RNA-Seq libraries were mea-
sured by three different methods: Nanodrop, Bioanalyzer, and RT-qPCR. Total DNA amount
measured by Nanodrop was more consistent with that measured by RT-qPCR for each sample,
while the measurements from Bioanalyzer were much lower for all cases (Fig 6B). Seven nano-
grams of each RNA-Seq library was pooled and sequenced to generate 75 bp single-end reads.
Despite using equal starting amounts of library based on Nanodrop measurements, the
Fig 4. Minimal sera volume for exosome detection and RNA extraction. (A) Representative immunoblots for CD63 comparing exosome enrichment using
ultracentrifugation (UC) and ExoQuick (EQ) among samples of varying volumes. (B) Scatter dot plots depict total exosomal RNA recovered per sample volume
using EQ. (C) Scatter dot plots show RNA quality measured by OD260/OD280 per sample volume. Data are shown as the mean ± standard deviation (SD) from six
independent patient samples. P-values were calculated using one-way ANOVA.
https://doi.org/10.1371/journal.pone.0196913.g004
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numbers of mapped raw reads were variable (Fig 6B). Correlation of library DNA amount to
resulting mapped reads for Nanodrop or qPCR was higher than that for Bioanalyzer (r = 0.7 vs
0.6), suggesting that Nanodrop and qPCR are more suitable for measuring the concentration
of RNA-Seq library than Bioanalyzer. RNA-Seq reads were mapped to the human genome and
annotated using GENCODE25 data to classify exosomal transcripts into functional groups
(Fig 6C). The most abundant biotype was protein-coding RNA (53%). Significant amount of
long non-coding RNAs, including lincRNAs (17%) and antisense transcripts (6%), were also
detected. Similar percentages of RNA with same biotypes were identified within those five
samples (Fig 6C).
Discussion
Although next-generation sequencing has transformed biomarker research, RNA-Seq profil-
ing of liquid biopsy specimens is a relatively underexplored frontier. Our optimized protocol
demonstrates that exosomes can be rapidly enriched from a very limited amount of fresh or
archival human cell-free serum (under 63 μL) with particularly high efficiency when using a
commercially available reagent–ExoQuick, followed by RNA extraction performed using TRI-
zol LS and the RNeasy Mini Kit. The exosomal RNA isolated using this protocol can be used
for many downstream applications–RT-qPCR, gene expression microarray analysis, and, as
demonstrated here, RNA-Seq analysis. RNA-Seq provides the most comprehensive characteri-
zation of exosomal transcriptomes, and can be used in functional modeling studies or in the
discovery of biomarkers that could be used in the clinic for diagnosis, prognostication, or for
assessing therapeutic response.
In contrast to RNA-Seq libraries built from RNA extracted from other sources (e.g. whole
cells), the number of mapped reads in sera exosomal RNA-Seq libraries showed poorer corre-
lations with quantifications performed using the Nanodrop, qPCR, and the Bioanalyzer. This
could be because the exosomal RNA concentrations are typically lower, and near the lower
limit of detection for Nanodrop. Nanodrop (or Qubit) measurements tend to overestimate
nucleic acid concentrations and have greater variability while Bioanalyzer analyses typically
Fig 5. Exosomal RNAs are stable over two decades. Dot plots of total RNA yield and OD260/OD280 from 105 EQ-
treated archival patient samples using the RNeasy Mini Kit combined with TRIzol LS. Storage time for each sample is
indicated on the x-axis. The Spearman’s rank correlations for RNA yield versus storing time and OD260/OD280 versus
storage time are 0.185 (P = 0.06) and 0.04 (P = 0.70), respectively.
https://doi.org/10.1371/journal.pone.0196913.g005
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underestimate concentration and demonstrate less variability. The accepted ‘gold-standard’ is
an RT-qPCR measurement approached based on a standard curve of known DNA concentra-
tions. Somewhat surprisingly, our results showed that for exosomal RNA-Seq libraries, Nano-
drop quantification correlates higher with RT-qPCR measurements than Bioanalyzer. We
therefore recommend estimating library concentration using Nanodrop and performing low-
depth sequencing (e.g. using the Illumina MiniSeq) to accurately quantify the ratio of each
library in the pool, and then adjusting the ratios as required before proceeding with deeper
Fig 6. Exosomal RNA-Seq libraries from archival sera specimens. (A) Bioanalyzer results for 5 independent specimens demonstrate inserted size of exosomal RNAs.
(B) Number of mapped reads generated from RNA-Seq libraries for 5 independent specimens with 20 ng exosomal RNAs. RNA-Seq library concentrations were
calculated using three different methods: Nanodrop, BioAnalyzer (BioA), and RT-qPCR (qPCR). The Spearman’s rank correlations for Nanodrop versus reads,
BioAnalyzer versus reads, and qPCR versus reads are 0.7 (P = 0.23), 0.6 (P = 0.35), and 0.7 (P = 0.23), respectively. (C) Relative abundance of biotypes detected for 5
exosomal RNA-Seq libraries from healthy female subjects. PC = protein coding, PP = processed pseudogene, lincRNA = long intergenic non-coding RNA,
UP = unprocessed pseudogene, snRNA = small nuclear RNA, miRNA = microRNA, TEC = to be experimentally confirmed, snoRNA = small nucleolar RNA,
TUP = transcribed unprocessed pseudogene.
https://doi.org/10.1371/journal.pone.0196913.g006
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sequencing. This strategy will provide equal number of reads for each library within the pool,
which is essential for quantitative analyses of exosomal RNAs across samples [42].
The ultracentrifugation protocol also performed well in our comparisons, but is only ame-
nable to smaller studies, as substantially more serum samples can be processed in a drastically
shorter time (at similar cost) using ExoQuick method (~18 h total processing time) compared
with ultracentrifugation (~56 h total processing time). Additionally, use of the ExoQuick
reagent retrieves more exosomes and exosomal RNAs than ultracentrifugation. Several meth-
ods of exosomal RNA extraction can be implemented, and it should be noted that precipitation
of RNA by absolute ethanol recovered more RNA from ExoQuick-purified exosomes, but not
ultracentrifugation-purified exosomes. Those exosomal RNAs had an average OD260/OD280 of
2.5, suggesting that small RNAs may be over-represented, as observed in previous studies [23,
24]. Therefore, ExoQuick treatment followed by traditional RNA precipitation is preferable if
small RNAs are of interest. Crucially, age of the sample does not appear to influence the RNA
yield, thus researchers can apply this technique to archival specimens that may have been
stored for many years, although low temperature storage is likely to be critical (our specimens
were stored at -80˚C). Moreover, this optimized protocol can be readily adapted to the pro-
cessing of other biospecimens such as urine, saliva, or stool and translation of this protocol
into the clinical setting for laboratory testing may also be feasible.
In the past decade, exosomal components have been examined extensively to identify
potential prognostic and diagnostic biomarkers for many human diseases, including cancer,
but exosomal transcriptomes remain poorly characterized [29, 30]. As exosomes are stable
over time, exosomal components uniquely secreted by diseased cells but not normal cells rep-
resent promising candidate biomarkers of human disease. Most exosomal RNAs are protein-
coding and long non-coding RNAs, which are of particularly interest as novel biomarkers due
to their higher cell-type specificity [38]. MiRNAs are also likely to be a key area of study as
they represent a particularly promising group of candidate biomarkers due to their inherent
stability. In summary, the current protocol provides an optimized strategy for novel biomarker
discovery in liquid sera specimens by comprehensive exosomal RNA profiling that can be
readily applied to a diverse array of human diseases.
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